Investors
2 investorsAll
Early stage
Mid stage
Late stage
Mid stage· 3
Wim Leereveld
Founder & former CEO Access to Medicine Foundation | Thought Leader| Lecturer| Founding Chair World Benchmarking Alliance | Societal Indices Leader; SEP & Chatham House. "Companies as a driver 4 Change"
Boardmember World Child Cancer NL
mid stage
Nov 2017
Wim Leereveld
Founder & former CEO Access to Medicine Foundation | Thought Leader| Lecturer| Founding Chair World Benchmarking Alliance | Societal Indices Leader; SEP & Chatham House. "Companies as a driver 4 Change"
Boardmember World Child Cancer
mid stage
Nov 2017
Patrick Kemmeren
senior Principal Investigator & head Big Data Core at Princess Máxima Center for Pediatric Oncology
Principal Investigator
mid stage
Jan 2016
Investor geography1 country
Investor activity2016–2019 · investors recorded per year
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Prinses Máxima Centrum voor kinderoncologie?
Prinses Máxima Centrum voor kinderoncologie has 2 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Prinses Máxima Centrum voor kinderoncologie last raise funding?
The most recent investment in Prinses Máxima Centrum voor kinderoncologie recorded on gritt.io was in June 2019.
When was Prinses Máxima Centrum voor kinderoncologie founded?
Prinses Máxima Centrum voor kinderoncologie was founded in 2018.
What industry is Prinses Máxima Centrum voor kinderoncologie in?
Prinses Máxima Centrum voor kinderoncologie operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Prinses Máxima Centrum voor kinderoncologie based?
Prinses Máxima Centrum voor kinderoncologie is headquartered in Utrecht, Netherlands.
